2 , P ϭ 0.02), but glucose potentiation (i.e., higher secretion at the same glycemia) was stronger (1.08 Ϯ 0.02-vs. 0.92 Ϯ 0.02-fold, P ϭ 0.006), the increment being higher in Study II (ϩ36 Ϯ 5%) than Study I (ϩ19 Ϯ 6%, P Ͻ 0.05). In pooled data, a higher glucose area during the first OGTT was associated with a higher potentiation during the second OGTT (rhoϭ0.60, P ϭ 0.002). Neither insulin clearance nor glucose clearance differed between loads, and appearance of glucose over 3 h totalled 60 Ϯ 6 g for the first load and 52 Ϯ 5 g for the second load (P ϭ not significant). Fasting endogenous glucose production [13.3 Ϯ 0.6 mol ⅐ min Ϫ1 ⅐ kg fat-free mass (FFM) Ϫ1 ] averaged 6.0 Ϯ 3.8 mol ⅐ min Ϫ1 ⅐ kg FFM Ϫ1 between 0 and 180 min and 1.7 Ϯ 2.6 between 180 and 360 min (P Ͻ 0.03). Glucose potentiation and stronger suppression of endogenous glucose release are the main mechanisms underlying the Staub-Traugott effect. glucose potentiation; glucose absorption; glucose tolerance IMPROVEMENT OF CARBOHYDRATE tolerance following repeated glucose administration was first reported by Hamman and Hirschman in 1919 (10) and subsequently confirmed by Staub in 1921 (24) and by Traugott in 1922 (27). This effect has since been known as the Staub-Traugott effect and has been demonstrated after oral (8,24,27) and intravenous administration of glucose (5-9).Despite the fact that this facilitated glucose disposal is an important physiological determinant of overall glycemic exposure, its mechanisms have not been established conclusively. Increased plasma insulin response has been reported by some studies (2, 3, 25), but not others (1,7,14,21,23,26,30); decreased hepatic clearance of insulin (30) and enhanced insulin sensitivity (13, 14) have also been proposed.On theoretical grounds, a lower glycemic response to a glucose load that follows another glucose challenge could be due to: 1) increased insulin secretion, 2) enhanced peripheral insulin sensitivity, 3) enhanced hepatic insulin sensitivity, 4) reduced absorption of oral glucose, or 5) a combination of the above. In the present study, we explored each of these mechanisms in healthy volunteers.
MATERIALS AND METHODSSubjects. Seventeen healthy subjects (Table 1) volunteered for the study. They gave no history of preexisting metabolic disorder or familial diabetes and were not taking any medication. None of them had lost weight or changed dietary habits during the 3 mo preceding the study. All subjects had resting arterial blood pressure Ͻ140/90 mmHg and normal results for liver and renal function tests. The study protocol was approved by the local Ethics Committee, and all subjects gave their informed consent to participate.Study protocol. Two studies were carried out in each subject after an overnight (12-to 14-h) fast, with a 2-wk interval. In the first study (Study I), subjects received two sequential oral glucose loads (75 g), the first at time 0 min and the second at time 180 min. Venous blood was sampled at timed intervals for plasma glucose, insulin, C-peptide, glucagon-...